Very early researchStudy completedNCT01221506What this trial is testingPazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)Who this might be right forCarcinoma, Renal Cell Abramson Cancer Center at Penn Medicine 20
Testing effectiveness (Phase 2)WithdrawnNCT03035630What this trial is testingSunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell CarcinomaWho this might be right forClear-cell Renal Cell CarcinomaRCCKidney Cancer+1 more Guru Sonpavde
Testing effectiveness (Phase 2)Study completedNCT01164228What this trial is testingSunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By SurgeryWho this might be right forKidney Cancer ECOG-ACRIN Cancer Research Group 87
Early research (Phase 1)Ended earlyNCT01943188What this trial is testingStereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer Stanford University 2
Testing effectiveness (Phase 2)Looking for participantsNCT06683846What this trial is testingIvonescimab in the Treatment of Multiple Advanced TumorsWho this might be right forPheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more Fudan University 400
Not applicableStudy completedNCT06883565What this trial is testingTertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort StudyWho this might be right forRenal Cell Carcinoma (RCC) Ding-Wei Ye 232
Testing effectiveness (Phase 2)Study completedNCT02989714What this trial is testingPhase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell CancerWho this might be right forRenal Cell Carcinoma University of Michigan Rogel Cancer Center 13
Large-scale testing (Phase 3)Study completedNCT03849118What this trial is testing89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON StudyWho this might be right forClear Cell Renal Cell Carcinoma Telix Pharmaceuticals (Innovations) Pty Limited 300
Testing effectiveness (Phase 2)Study completedNCT03685448What this trial is testingANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)Who this might be right forRenal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35
Testing effectiveness (Phase 2)Looking for participantsNCT03972657What this trial is testingA Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsWho this might be right forMetastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC) Regeneron Pharmaceuticals 345
Not applicableStudy completedNCT02499458What this trial is testingProspective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal CancerWho this might be right forClear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial Cells+2 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 44
Testing effectiveness (Phase 2)Study completedNCT00566995What this trial is testingPhase II Study of Vandetanib in Individuals With Kidney CancerWho this might be right forRenal CancerVon Hippel Lindau National Cancer Institute (NCI) 37
Post-approval studies (Phase 4)Ended earlyNCT00930345What this trial is testingBiological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)Study completedNCT02978404What this trial is testingCombining Radiosurgery and Nivolumab in the Treatment of Brain MetastasesWho this might be right forClear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more Centre hospitalier de l'Université de Montréal (CHUM) 26
Not applicableStudy completedNCT01118078What this trial is testingBiomarkers in Tissue Samples From Patients With High-Risk Wilms TumorWho this might be right forClear Cell Sarcoma of the KidneyRecurrent Wilms Tumor and Other Childhood Kidney TumorsRhabdoid Tumor of the Kidney+5 more Children's Oncology Group 185
Testing effectiveness (Phase 2)Study completedNCT03693612What this trial is testingGSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 26
Not applicableLooking for participantsNCT06088134What this trial is testingContrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)Who this might be right forClear Cell Renal Cell CarcinomaPrognostic Cancer ModelRecurrent Renal Cell Cancer Mingzhao Xiao 800
Large-scale testing (Phase 3)Active Not RecruitingNCT05239728What this trial is testingBelzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)Who this might be right forCarcinoma, Renal Cell Merck Sharp & Dohme LLC 1,800
Early research (Phase 1)Looking for participantsNCT07072234What this trial is testingPhase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell CarcinomaPhase 1Growth Factor M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT00301990What this trial is testingBevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Jonsson Comprehensive Cancer Center 65